Device type · NIG
System, Test, Carbohydrate Antigen (Ca19-9), For Monitoring And Management Of Pancreatic Cancer
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
NIG
Immunology
Device class
Class II
FDA decisions since 2015
4
510(k), De Novo and PMA
Adverse event reports
107
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- System, Test, Carbohydrate Antigen (Ca19-9), For Monitoring And Management Of Pancreatic Cancer
- Product code
- NIG
- Device class
- Class II
- Review panel
- Immunology
- Regulation
- 21 CFR 866.6010
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for NIG
Latest FDA decisions
- Atellica IM CA 19-9 II510(k)
Siemens Healthcare Diagnostics, Inc.
K253528 · Decided Aug 10, 2026 · 270 days after receipt
Device type: System, Test, Carbohydrate Antigen (Ca19-9), For Monitoring And Management Of Pancreatic Cancer (NIG) · Laboratory Medicine & Pathology
K231525 · Decided Aug 9, 2023 · 75 days after receipt
Device type: System, Test, Carbohydrate Antigen (Ca19-9), For Monitoring And Management Of Pancreatic Cancer (NIG) · Laboratory Medicine & Pathology
- Lumipulse G CA19-9-N510(k)
K200997 · Decided May 14, 2020 · 28 days after receipt
Device type: System, Test, Carbohydrate Antigen (Ca19-9), For Monitoring And Management Of Pancreatic Cancer (NIG) · Laboratory Medicine & Pathology
1 more FDA decisions with a free account
Reports received
107
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
106
99% of reports
Injury reports
1
0.9% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 7 | 0 | 0 | 0 |
| Jan 24 | 5 | 0 | 0 | 0 |
| Feb 24 | 8 | 0 | 0 | 0 |
| Mar 24 | 3 | 0 | 0 | 0 |
| Apr 24 | 14 | 1 | 0 | 0 |
| May 24 | 22 | 1 | 0 | 0 |
| Jun 24 | 14 | 0 | 0 | 0 |
| Jul 24 | 10 | 0 | 0 | 0 |
| Aug 24 | 10 | 0 | 0 | 0 |
| Sep 24 | 13 | 0 | 0 | 0 |
| Oct 24 | 11 | 0 | 0 | 0 |
| Nov 24 | 4 | 0 | 0 | 0 |
| Dec 24 | 5 | 0 | 0 | 0 |
| Jan 25 | 7 | 0 | 0 | 0 |
| Feb 25 | 6 | 0 | 0 | 0 |
| Mar 25 | 9 | 0 | 0 | 0 |
| Apr 25 | 15 | 0 | 0 | 0 |
| May 25 | 9 | 0 | 0 | 0 |
| Jun 25 | 11 | 0 | 0 | 0 |
| Jul 25 | 5 | 0 | 0 | 0 |
| Aug 25 | 7 | 0 | 0 | 0 |
| Sep 25 | 9 | 0 | 0 | 0 |
| Oct 25 | 8 | 0 | 0 | 0 |
| Nov 25 | 5 | 0 | 0 | 0 |
| Dec 25 | 9 | 0 | 0 | 0 |
| Jan 26 | 9 | 0 | 0 | 0 |
| Feb 26 | 8 | 0 | 0 | 0 |
| Mar 26 | 13 | 0 | 0 | 0 |
| Apr 26 | 9 | 0 | 0 | 0 |
| May 26 | 6 | 0 | 0 | 0 |
| Jun 26 | 14 | 1 | 0 | 0 |
| Jul 26 | 15 | 0 | 0 | 0 |
| Aug 26 | 5 | 0 | 0 | 0 |
| Sep 26 | 7 | 0 | 0 | 0 |
| Oct 26 | 6 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
- Abbott55
1 more in this ranking with a free account
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- High Test Results87
- Non Reproducible Results28
- Low Test Results19
7 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions106
- Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available1
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Siemens Healthcare Diagnostics, Inc.
Z-3100-2024 · Started Jul 26, 2024 · Posted by FDA Sep 11, 2024
Reason given: Positive bias for some samples around the CA 19-9 upper limit of normal of 35 U/m as compared to the previous lot. The sample bias observed was greatest in the Asia Pacific sample population. The observed bias is not proportional across the assay measuring interval and is less pronounced for sample results above a...
Cause as FDA categorized it: Under Investigation by firm
Siemens Healthcare Diagnostics, Inc.
Z-3101-2024 · Started Jul 26, 2024 · Posted by FDA Sep 11, 2024
Reason given: Positive bias for some samples around the CA 19-9 upper limit of normal of 35 U/m as compared to the previous lot. The sample bias observed was greatest in the Asia Pacific sample population. The observed bias is not proportional across the assay measuring interval and is less pronounced for sample results above a...
Cause as FDA categorized it: Under Investigation by firm
Siemens Healthcare Diagnostics, Inc.
Z-3102-2024 · Started Jul 26, 2024 · Posted by FDA Sep 11, 2024
Reason given: Positive bias for some samples around the CA 19-9 upper limit of normal of 35 U/m as compared to the previous lot. The sample bias observed was greatest in the Asia Pacific sample population. The observed bias is not proportional across the assay measuring interval and is less pronounced for sample results above a...
Cause as FDA categorized it: Under Investigation by firm
16 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.